Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
entrez:
24
8
2021
pubmed:
25
8
2021
medline:
1
9
2021
Statut:
ppublish
Résumé
Cancer Informatics for Cancer Centers (CI4CC) is a grassroots, nonprofit 501c3 organization intended to provide a focused national forum for engagement of senior cancer informatics leaders, primarily aimed at academic cancer centers anywhere in the world but with a special emphasis on the 70 National Cancer Institute-funded cancer centers. This consortium has regularly held topic-focused biannual face-to-face symposiums. These meetings are a place to review cancer informatics and data science priorities and initiatives, providing a forum for discussion of the strategic and pragmatic issues that we faced at our respective institutions and cancer centers. Here, we provide meeting highlights from the latest CI4CC Symposium, which was delayed from its original April 2020 schedule because of the COVID-19 pandemic and held virtually over three days (September 24, October 1, and October 8) in the fall of 2020. In addition to the content presented, we found that holding this event virtually once a week for 6 hours was a great way to keep the kind of deep engagement that a face-to-face meeting engenders. This is the second such publication of CI4CC Symposium highlights, the first covering the meeting that took place in Napa, California, from October 14-16, 2019. We conclude with some thoughts about using data science to learn from every child with cancer, focusing on emerging activities of the National Cancer Institute's Childhood Cancer Data Initiative.
Identifiants
pubmed: 34428097
doi: 10.1200/CCI.21.00040
pmc: PMC8763339
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
881-896Subventions
Organisme : NCI NIH HHS
ID : R21 CA205309
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA151284
Pays : United States
Organisme : NHLBI NIH HHS
ID : U2C HL138346
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA220457
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216391
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA177558
Pays : United States
Organisme : HHS
ID : HHSN26100001
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180899
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201800013I
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011754
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011852
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216354
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180886
Pays : United States
Références
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1241-2
pubmed: 16835317
J Adolesc Young Adult Oncol. 2013 Jun;2(2):59-65
pubmed: 23781402
Med Care. 2018 Jun;56(6):e32-e38
pubmed: 28731893
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1929-1939
pubmed: 32404444
Cancer Med. 2019 May;8(5):2095-2103
pubmed: 30912628
Semin Oncol. 2015 Oct;42(5):681-5
pubmed: 26433549
JCO Clin Cancer Inform. 2020 Feb;4:108-116
pubmed: 32078367
N Engl J Med. 1948 Jun 3;238(23):787-93
pubmed: 18860765
N Engl J Med. 2010 Sep 30;363(14):1324-34
pubmed: 20879881
JAMA Netw Open. 2019 Oct 2;2(10):e1913968
pubmed: 31651965
Circulation. 2019 Sep 17;140(12):1041-1043
pubmed: 31446776
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Blood. 1960 Mar;15:350-9
pubmed: 14401649
J Clin Oncol. 2014 Sep 20;32(27):3021-32
pubmed: 25092781
Med Care. 2015 Dec;53(12):1018-26
pubmed: 26492211
mSystems. 2019 Aug 20;4(4):
pubmed: 31431509
Nat Rev Genet. 2020 Oct;21(10):615-629
pubmed: 32694666
JCO Precis Oncol. 2018;2:
pubmed: 31372595
Int J Cancer. 2013 Nov 15;133(10):2444-53
pubmed: 23661176
Cancer. 2018 Oct 1;124(19):3900-3908
pubmed: 30291793
Cell. 2020 Dec 23;183(7):1962-1985.e31
pubmed: 33242424
JAMA Oncol. 2020 Mar 1;6(3):393-401
pubmed: 31971547
J Clin Oncol. 2016 May 10;34(14):1626-33
pubmed: 26951318
J Palliat Med. 2016 Nov;19(11):1136-1141
pubmed: 27482745
Nat Genet. 2017 Aug;49(8):1261-1266
pubmed: 28650485
J Natl Cancer Inst. 2017 Nov 1;109(11):
pubmed: 29059430
Lancet Oncol. 2020 Apr;21(4):541-550
pubmed: 32192573
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
JAMA Oncol. 2015 Aug;1(5):592-600
pubmed: 26181778
N Engl J Med. 2020 Apr 9;382(15):1430-1442
pubmed: 32187457
Nat Med. 2014 Apr;20(4):436-42
pubmed: 24584119
J Clin Oncol. 2020 Sep 20;38(27):3161-3174
pubmed: 32673152
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1280-9
pubmed: 24925676
Cancer. 2014 Oct 1;120(19):3007-15
pubmed: 24889136
BMC Cancer. 2014 Nov 03;14:805
pubmed: 25367402
J Clin Oncol. 2009 May 10;27(14):2308-18
pubmed: 19364948
Nature. 2018 Mar 15;555(7696):371-376
pubmed: 29489755
Cancer. 2019 May 1;125(9):1558-1567
pubmed: 30620388
Cold Spring Harb Mol Case Stud. 2019 Oct 23;5(5):
pubmed: 31645344
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):336-342
pubmed: 31959598
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Mod Pathol. 2015 Dec;28(12):1613-20
pubmed: 26564007
J Clin Oncol. 2009 May 10;27(14):2319-27
pubmed: 19364957
mSystems. 2019 Aug 20;4(4):
pubmed: 31431510
J Registry Manag. 2020 Fall;47(3):127-134
pubmed: 34128919
Adv Radiat Oncol. 2016 Oct 13;1(4):260-271
pubmed: 28740896
Cancer. 2019 Nov 1;125(21):3729-3737
pubmed: 31381143
Int J Cancer. 2003 May 20;105(1):88-91
pubmed: 12672035
J Clin Oncol. 2019 Aug 20;37(24):2131-2140
pubmed: 31260642
J Neurooncol. 2017 May;132(3):507-512
pubmed: 28285334
J Clin Oncol. 2016 May 1;34(13):1537-43
pubmed: 26884558
Br J Radiol. 2020 Mar;93(1107):20190673
pubmed: 31600082
Br J Cancer. 2018 Oct;119(7):864-872
pubmed: 30287918
N Engl J Med. 2016 Mar 3;374(9):833-42
pubmed: 26761625
Semin Oncol. 2008 Oct;35(5):484-93
pubmed: 18929147